Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 168

Sort by

Sort Order Select

Journal Articles

Haploidentical Transplantation with Post-Transplant Cyclophosphamide Versus Single Cord Blood Transplantation for Adults with Relapsed/Refractory Malignant Lymphoma

Masashi Nishikubo, Yoshimitsu Shimomura, Yosuke Nakaya, Akihito Shinohara, Naoyuki Uchida, Nobuyuki Takayama, Hikaru Kobayashi, Yasufumi Uehara, Jun Ishikawa, Kazuya Ishiwata, Nobuhiro Hiramoto, Hideyuki Nakazawa, Fumihiko Ishimaru, Takahiro Fukuda, Yoshinobu Kanda, Yoshiko Atsuta, Eisei Kondo, Shinichi Kako

Blood (2023) 142 (Supplement 1): 3607.

https://doi.org/10.1182/blood-2023-178951

Published: 2023

Journal Articles

Donor NK Cell Education By KIR3DL1 and HLA-B Associates with Reduced Relapse in Unrelated Bone Marrow Transplantation for Adult T-Cell Leukemia

Blood (2023) 142 (Supplement 1): 4982.

https://doi.org/10.1182/blood-2023-185474

Published: 2023

Journal Articles

Outcomes and Prognostic Factors of Second Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: A Study from the Adult Acute Lymphoblastic Leukemia Working Group of the Japanese Society for Transplantation and Cellular Therapy

Kimimori Kamijo, Yoshimitsu Shimomura, Takayoshi Tachibana, Yuho Najima, Jun Aoki, Yu Akahoshi, Masatsugu Tanaka, Noriko Doki, Naoyuki Uchida, Hiroyuki Ohigashi, Hikaru Kobayashi, Shuichi Ota, Miho Nara, Shinichiro Fujiwara, Yasuo Mori, Yoshinobu Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Yasuyuki Arai

Blood (2023) 142 (Supplement 1): 4958.

https://doi.org/10.1182/blood-2023-180602

Published: 2023

Journal Articles

Prevalence and Outcome of Vexas Syndrome in Unrelated Hematopoietic Stem Cell Transplantation

Blood (2023) 142 (Supplement 1): 1354.

https://doi.org/10.1182/blood-2023-190791

Published: 2023

Journal Articles

Impact of Conditioning Intensity and Regimen on Outcomes after Unrelated Cord Blood Transplantation for Patients with Myelodysplastic Syndrome

Machiko Fujioka, Hidehiro Itonaga, Yasushi Miyazaki, Yoshimitsu Shimomura, Naoyuki Uchida, Satoshi Takahashi, Makoto Onizuka, Yasunori Ueda, Yasufumi Uehara, Masatsugu Tanaka, Yoshiko Matsuhashi, Shigesaburo Miyakoshi, Haruyuki Tanaka, Toshiro Kawakita, Fumihiko Ishimaru, Junya Kanda, Tatsuo Ichinohe, Yoshiko Atsuta, Ken Ishiyama

Blood (2023) 142 (Supplement 1): 3536.

https://doi.org/10.1182/blood-2023-179157

Published: 2023

Journal Articles

Prognostic Impact of Conditioning Intensity on Outcomes after Allogeneic Transplantation for MDS with Low Blasts

Hidehiro Itonaga, Yasushi Miyazaki, Machiko Fujioka, Ken Ishiyama, Jun Aoki, Noriko Doki, Tetsuya Nishida, Takahiro Fukuda, Naoyuki Uchida, Yasunori Ueda, Yasufumi Uehara, Yuta Katayama, Makoto Onizuka, Tatsuo Ichinohe, Yoshiko Atsuta

Blood (2023) 142 (Supplement 1): 4985.

https://doi.org/10.1182/blood-2023-173567

Published: 2023

Journal Articles

The HLA-B Leader MM Genotype Has a Negative Impact on Outcomes in HLA-B One Antigen Mismatched and HLA-B Matched Cord Blood Transplantation without Anti-Thymocyte Globulin: Analysis of the Japanese Society for Transplantation and Cellular Therapy

Blood (2023) 142 (Supplement 1): 1048.

https://doi.org/10.1182/blood-2023-178905

Published: 2023

Journal Articles

Clonal Evolution of Der(1;7)(q10;p10) Myeloid Neoplasms

Blood (2023) 142 (Supplement 1): 1000.

https://doi.org/10.1182/blood-2023-185857

Published: 2023

Journal Articles

Effect of Early Cytomegalovirus Reactivation on Relapse in Adult Patients with Myelodysplastic Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation: A Registry Study from the Japan Society for Transplantation and Cellular Therapy (JSTCT)

Tatsuya Konishi, Kensuke Matsuda, Hidehiro Itonaga, Noriko Doki, Tetsuya Nishida, Ken-Ichi Matsuoka, Takashi Ikeda, Yoshinobu Kanda, Takahiro Fukuda, Junya Kanda, Hirohisa Nakamae, Tatsuo Ichinohe, Yoshiko Atsuta, Ken Ishiyama

Blood (2023) 142 (Supplement 1): 2170.

https://doi.org/10.1182/blood-2023-172414

Published: 2023

Journal Articles

Comparison of Non-Relapse Mortality after Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide Versus Single Umbilical Cord Blood Transplantation for Hematologic Disease

Kaito Harada, Junya Kanda, Masahiro Hirayama, Fumiya Wada, Naoyuki Uchida, Hirohisa Nakamae, Masatsugu Tanaka, Makoto Onizuka, Hiroyuki Ohigashi, Nobuaki Nakano, Takahiro Fukuda, Kazuya Ishiwata, Yumiko Maruyama, Tetsuya Eto, Fumihiko Ishimaru, Yoshiko Atsuta, Hideki Nakasone, Takashi Tanaka

Blood (2023) 142 (Supplement 1): 4905.

https://doi.org/10.1182/blood-2023-184821

Published: 2023

Journal Articles

Allogeneic (Allo-SCT) Versus Autologous Stem-Cell Transplantation (Auto-SCT) after Relapse to First Line Auto-SCT in Multiple Myeloma: A Meta-Analysis with Predominantly Individual Patient Data

Heinz Ludwig, Takashi Ikeda, Cesar O. Freytes, Koji Kawamura, Yoshiko Atsuta, Hiroyuki Takamatsu, David H. Vesole, Hari Parameswaran, Axel Hinke

Blood (2023) 142 (Supplement 1): 7100.

https://doi.org/10.1182/blood-2023-179105

Published: 2023

Journal Articles

Cytomegalovirus-Seronegative Plus Leukoreduced Blood Products Are Still Superior to Only Leukoreduced Products in Preventing Transfusion-Transmitted Cytomegalovirus Infection

Kimikazu Yakushijin, Ryu Yanagisawa, Sachiko Seo, Masao Ogata, Michiko Kajiwara, Naoyuki Uchida, Youko Suehiro, Noriko Doki, Daiichiro Hasegawa, Satoshi Yoshihara, Kensuke Usuki, Katsuyoshi Koh, Yoshinobu Kanda, Mineo Kurokawa, Makoto Onizuka, Fumihiko Ishimaru, Yoshiko Atsuta, Takahiro Fukuda, Hideki Nakasone

Blood (2023) 142 (Supplement 1): 2666.

https://doi.org/10.1182/blood-2023-178182

Published: 2023

Journal Articles

Outcomes of Allogeneic Transplantation for Adult T-Cell Leukemia/Lymphoma in Adolescents and Young Adult (AYA) and Young Patients

Hidehiro Itonaga, Takuya Fukushima, Koji Kato, Nobuaki Nakano, Takeharu Kato, Takashi Tanaka, Tetsuya Eto, Yasuo Mori, Toshiro Kawakita, Naoyuki Uchida, Yasushi Sawayama, Takahiro Fukuda, Yoshinobu Kanda, Yoshiko Atsuta, Makoto Yoshimitsu, Shigeo Fuji

Blood (2023) 142 (Supplement 1): 1707.

https://doi.org/10.1182/blood-2023-173590

Published: 2023

Journal Articles

Impact of Age on Outcome in Newly Diagnosed Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Cell Transplantation from the Worldwide Network for Blood and Marrow Transplantation Global Study

Blood (2023) 142 (Supplement 1): 785.

https://doi.org/10.1182/blood-2023-179153

Published: 2023

Journal Articles

The Comparison between BM and PBSC for the Patients with Pre-Transplant Pulmonary Dysfunction in HLA-Matched Allo-HCT: Subgroup Analysis Exploring the Impact Based on HCT Factors

Blood (2023) 142 (Supplement 1): 3609.

https://doi.org/10.1182/blood-2023-174431

Published: 2023

Journal Articles

Impact of Letermovir Prophylaxis for Cytomegalovirus Reactivation on Post-Transplant Outcomes 100 Days before and after Allogeneic Hematopoietic Cell Transplantation

Blood (2023) 142 (Supplement 1): 4898.

https://doi.org/10.1182/blood-2023-180906

Published: 2023

Journal Articles

Impact of Early Anti-Cytomegalovirus Therapy on the Incidence of Chronic Graft-Versus-Host Disease

Kotaro Miyao, Makoto Murata, Tetsuya Nishida, Yukiyasu Ozawa, Naoyuki Uchida, Takahiro Fukuda, Noriko Doki, Tetsuya Eto, Toshiro Kawakita, Yasuo Mori, Satoru Takada, Hiroyuki Ohigashi, Masatsugu Tanaka, Yoshinobu Kanda, Ken-ichi Matsuoka, Fumihiko Ishimaru, Yoshiko Atsuta, Junya Kanda, Seitaro Terakura

Blood (2023) 142 (Supplement 1): 6993.

https://doi.org/10.1182/blood-2023-178592

Published: 2023

Journal Articles

Patterns of Graft-Versus-Host Disease (GvHD) Prevention and Management in the Eastern Mediterranean (EM) Region: A Worldwide Network for Blood & Marrow Transplantation (WBMT) Survey

Blood (2023) 142 (Supplement 1): 7029.

https://doi.org/10.1182/blood-2023-182995

Published: 2023

Journal Articles

Identifying the Optimal Conditioning Intensity of Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia in Complete Remission

Blood (2023) 142 (Supplement 1): 2150.

https://doi.org/10.1182/blood-2023-181621

Published: 2023

Journal Articles

Development of a Stacked Ensemble Model for Risk Stratification of Chronic Gvhd after Allogeneic HSCT: Trump Cohort Study

Blood (2023) 142 (Supplement 1): 3561.

https://doi.org/10.1182/blood-2023-173779

Published: 2023

NARROW

Haploidentical Transplantation with Post-Transplant Cyclophosphamide Versus Single Cord Blood Transplantation for Adults with Relapsed/Refractory Malignant Lymphoma

Donor NK Cell Education By KIR3DL1 and HLA-B Associates with Reduced Relapse in Unrelated Bone Marrow Transplantation for Adult T-Cell Leukemia

Outcomes and Prognostic Factors of Second Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: A Study from the Adult Acute Lymphoblastic Leukemia Working Group of the Japanese Society for Transplantation and Cellular Therapy

Prevalence and Outcome of Vexas Syndrome in Unrelated Hematopoietic Stem Cell Transplantation

Impact of Conditioning Intensity and Regimen on Outcomes after Unrelated Cord Blood Transplantation for Patients with Myelodysplastic Syndrome

Prognostic Impact of Conditioning Intensity on Outcomes after Allogeneic Transplantation for MDS with Low Blasts

The HLA-B Leader MM Genotype Has a Negative Impact on Outcomes in HLA-B One Antigen Mismatched and HLA-B Matched Cord Blood Transplantation without Anti-Thymocyte Globulin: Analysis of the Japanese Society for Transplantation and Cellular Therapy

Clonal Evolution of Der(1;7)(q10;p10) Myeloid Neoplasms

Effect of Early Cytomegalovirus Reactivation on Relapse in Adult Patients with Myelodysplastic Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation: A Registry Study from the Japan Society for Transplantation and Cellular Therapy (JSTCT)

Comparison of Non-Relapse Mortality after Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide Versus Single Umbilical Cord Blood Transplantation for Hematologic Disease

Allogeneic (Allo-SCT) Versus Autologous Stem-Cell Transplantation (Auto-SCT) after Relapse to First Line Auto-SCT in Multiple Myeloma: A Meta-Analysis with Predominantly Individual Patient Data

Cytomegalovirus-Seronegative Plus Leukoreduced Blood Products Are Still Superior to Only Leukoreduced Products in Preventing Transfusion-Transmitted Cytomegalovirus Infection

Outcomes of Allogeneic Transplantation for Adult T-Cell Leukemia/Lymphoma in Adolescents and Young Adult (AYA) and Young Patients

Impact of Age on Outcome in Newly Diagnosed Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Cell Transplantation from the Worldwide Network for Blood and Marrow Transplantation Global Study

The Comparison between BM and PBSC for the Patients with Pre-Transplant Pulmonary Dysfunction in HLA-Matched Allo-HCT: Subgroup Analysis Exploring the Impact Based on HCT Factors

Impact of Letermovir Prophylaxis for Cytomegalovirus Reactivation on Post-Transplant Outcomes 100 Days before and after Allogeneic Hematopoietic Cell Transplantation

Impact of Early Anti-Cytomegalovirus Therapy on the Incidence of Chronic Graft-Versus-Host Disease

Patterns of Graft-Versus-Host Disease (GvHD) Prevention and Management in the Eastern Mediterranean (EM) Region: A Worldwide Network for Blood & Marrow Transplantation (WBMT) Survey

Identifying the Optimal Conditioning Intensity of Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia in Complete Remission

Development of a Stacked Ensemble Model for Risk Stratification of Chronic Gvhd after Allogeneic HSCT: Trump Cohort Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only